Vi polysaccharide typhoid vaccine (Lanzhou Institute of Biological Products)

伤寒vi多糖疫苗（兰州生物制品研究所）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameVi polysaccharide typhoid vaccine (Lanzhou Institute of Biological Products)

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Bacterial vaccineVaccines > Development/production technology > Inactivated vaccine > Split vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsTyphoid Fever

Global Approved IndicationsTyphoid Fever

Approved Indications in ChinaTyphoid Fever

Original Approved Country/TerritoryMainland China

Original Approved Date1996/01/01

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesLanzhou Institute Of Biological Products Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesLanzhou Institute Of Biological Products Co Ltd

Inactive CompaniesN/A

Active IndicationsTyphoid Fever

Inactive IndicationsN/A

Other Information

ATC CodeJ07AP03